A novel TB vaccine candidate that could replace the bacille Calmette-Guerin vaccine and has been found to provide significantly better protection against the TB germ in South African newborns, is set to reach a new benchmark in the new year as it will be tested on teenagers and adults with latent TB.
IAVI and Zendal Announce Funding for Efficacy Trial of Promising TB Vaccine Candidate in Africa kansascity.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kansascity.com Daily Mail and Mail on Sunday newspapers.
IAVI and Zendal Announce Funding for Efficacy Trial of Promising TB Vaccine Candidate in Africa sierraleonetimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sierraleonetimes.com Daily Mail and Mail on Sunday newspapers.
IAVI and Zendal Announce Funding for Efficacy Trial of Promising TB Vaccine Candidate in Africa charlotteobserver.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from charlotteobserver.com Daily Mail and Mail on Sunday newspapers.
IAVI and Zendal Announce Funding for Efficacy Trial of Promising TB Vaccine Candidate in Africa zimbabwestar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zimbabwestar.com Daily Mail and Mail on Sunday newspapers.